Psychosocial, psychiatric, and clinical implications of diabetic foot ulceration: A prospective analysis

Abstract

Background: Foot ulceration is very common complication of diabetes. Prevalence of psychiatric disorders is considered to be more in patients suffering from diabetic foot ulcers. Aim: The present study was carried out to observe and evaluate the various psychiatric disorders experienced by patients with diabetic foot ulceration, management of these disorders, and the metabolic abnormalities associated with the use of antipsychotic drugs. Materials and Methods: In this observational study, 293 patients in the age group of 25-70 years of either sex, who visited this hospital for the management of diabetic foot ulcers, were included after taking informed consent. They were prospectively followed for a period of 24 months. A phenomenological approach using semi-structured, conversational interviews was used. They were interviewed for the type of diabetes, duration of diabetes and duration of foot ulcer and other complications, type of treatment for diabetes and diabetic foot, psychosocial effects of foot ulceration on their daily The Hamilton rating scale for depression, questionnaire was used for assessing depression while the Hamilton anxiety rating scale questionnaire was used to rate the severity of anxiety. The data collected and analyzed for the type of psychiatric disorder, treatment options, type of drugs given and any side effects or complications occur as a result of these drugs. Descriptive statistical methods were used to analyze the data. Conclusion: Diabetic foot ulcer is associated with an increased incidence of various psychiatric disorders, depression being the most common among these. Drugs used to treat depression and associated with metabolic disturbances. Hyperglycemia associated with the use of antidepressants and antipsychotics further worsens the foot ulceration. Coordination between different specialties is important to manage the clinical, biological, and psychosocial aspects of this critical illness.

Anxiety - depression - diabetic foot ulcer - psychiatric aspects

• References

• 1 Shahi SK, Kumar A, Kumar S, Singh SK, Gupta SK, Singh TB. Prevalence of diabetic foot ulcer and associated risk factors in diabetic patients from North India. J Diabet Foot Complications 2012; 4: 83-91
• 2 Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ. et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: A population-based study. Diabet Med 1994; 11: 480-484
• 3 Scott G. The diabetic foot examination: A positive step in the prevention of diabetic foot ulcers and amputation. Osteopath Fam Physician 2013; 5: 73-78
• 4 Diabetes foot care: step-by-step. Available from:. http://www.worlddiabetesfoundation.org/projects/India Tanzania-WDF03-056 [Last accessed on 2014 Jun 05].
• 5 Bajwa SS, Sehgal V. Psycho-social and clinical aspects of diabeto-criticare. J Soc Health Diabet 2013; 1: 70-74
• 6 Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55
• 7 Hamilton Depression Scale. Available from: http://www.psychcongress.com/saundras-corner/scales-screeners/depression/hamilton-depression-rating-scale-ham-d [Last accessed on 2014 Jun 05].
• 8 Hedlund JL, Viewing BW. The Hamilton rating scale for depression. J oper psychiatry 1979; 10: 149-165
• 9 Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001; 24: 1069-1078
• 10 Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care 2000; 23: 934-942
• 11 de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosom Med 2001; 63: 619-630
• 12 Moosa MY, Panz VR, Jeenah FY, Joffe BI. African women with depression: The effect of imipramine and fluoxetine on body mass index and leptin secretion. J Clin Psychopharmacol 2003; 23: 549-552
• 13 Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH. et al. Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59: 241-250
• 14 Laimer M, Kramer-Reinstadler K, Rauchenzauner M, Lechner-Schoner T, Strauss R, Engl J. et al. Effect of mirtazapine treatment on body composition and metabolism. J Clin Psychiatry 2006; 67: 421-424
• 15 Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with diabetes and their first foot ulcer. The role of depression on mortality Published ahead of print at. Available from: http://www.care.diabetesjournals.org on 15 March 2007 DOI: 102337/dc06-2313 [Last accessed on 2014 Jun 05].
• 16 Carrington AL, Mawdsley SK, Morley M, Kincey J, Boulton AJ. Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract 1996; 32: 19-25
• 17 An Epidemiologic Study of Diabetes-Related Foot Ulcers Issues Related to Prevention and Mortality Based on the Nord-Trøndelag Health Study HUNT Marjolein MemelinkIversen Department of Public Health and Primary Health Care, Section of Nursing Sciences. Norway: University of Bergen; https://bora.uib.no/…/Dr.thesis_Marjolein%20M.%20Iversen.pdf [Last accessed on 2014 Jun 05].
• 18 Bajwa SJ, Kalra S. Diabeto-anaesthesia: A subspecialty needing endocrine introspection. Indian J Anaesth 2012; 56: 513-517
• 19 Kivimäki M, Hamer M, Batty GD, Geddes JR, Tabak AG, Pentti J. et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: A population-based study. Diabetes Care 2010; 33: 2611-2616
• 20 Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009; 166: 591-598
• 21 Monami M, Longo R, Desideri CM, Masotti G, Marchionni N, Mannucci E. The diabetic person beyond a foot ulcer: Healing, recurrence, and depressive symptoms. J Am Podiatr Med Assoc 2008; 98: 130-136
• 22 Ragnarson TennvallG, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000; 14: 235-241
• 23 Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med 2009; 26: 153-161
• 24 Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20: 585-590
• 25 Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE. et al. Anxiety and poor glycemic control: A meta-analytic review of the literature. Int J Psychiatry Med 2002; 32: 235-247
• 26 Nancy R, Megas MSN. CRNP: How Depression and anxiety affect patient adherence. Available from: http://www.podiatrytoday.com/how-depression-and-anxiety-affect-patient-adherence [Last accessed on 2014 Jun 05].